Normal view MARC view ISBD view

Gaussian laser-beam-diameter measurement using sinusoidal and triangular rulings. [electronic resource]

By:

Karim, M A

Contributor(s):

Producer: 20121002Description: 93-5 p. digitalISSN:

0146-9592

Online resources:

Available from publisher's website

In: Optics letters vol. 12

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

101 Clinical Pharmacokinetics of Systemically Administered Antileishmanial Drugs.
by Kip, Anke E
102 High-performance liquid chromatographic analysis of the anticancer drug irinotecan (CPT-11) and its active metabolite SN-38 in human plasma.
by Schoemaker, Nadja E
103 Quantitative bioanalysis of peptides by liquid chromatography coupled to (tandem) mass spectrometry.
by van den Broek, Irene
104 Efficacy of novel P-glycoprotein inhibitors to increase the oral uptake of paclitaxel in mice.
by Bardelmeijer, Heleen A
105 The effects of sulfur-containing compounds and gemcitabine on the binding of cisplatin to plasma proteins and DNA determined by inductively coupled plasma mass spectrometry and high performance liquid chromatography-inductively coupled plasma mass spectrometry.
by Brouwers, Elke E M
106 Carboplatin dosing in overweight and obese patients with normal renal function, does weight matter?
by Ekhart, Corine
107 Quantitative determination of capecitabine and its six metabolites in human plasma using liquid chromatography coupled to electrospray tandem mass spectrometry.
by Deenen, Maarten J
108 Taxanes: old drugs, new oral formulations.
by Jibodh, Rajni A
109 Reply to T. Magnes et al.
by Deenen, Maarten J
110 Development, validation, and clinical application of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of total intracellular β-decitabine nucleotides and genomic DNA incorporated β-decitabine and 5-methyl-2'-deoxycytidine.
by Roosendaal, Jeroen
111 Bioanalytical liquid chromatography-tandem mass spectrometric assay for the quantification of the ALK inhibitors alectinib, brigatinib and lorlatinib in plasma and mouse tissue homogenates.
by Sparidans, Rolf W
112 Multiparameter Flow Cytometry Assay for Quantification of Immune Cell Subsets, PD-1 Expression Levels and PD-1 Receptor Occupancy by Nivolumab and Pembrolizumab.
by Pluim, Dick
113 The application of inductively coupled plasma mass spectrometry in clinical pharmacological oncology research.
by Brouwers, Elke E M
114 Liquid chromatography-tandem mass spectrometric assay for the light sensitive tyrosine kinase inhibitor axitinib in human plasma.
by Sparidans, Rolf W
115 Extensive metabolism and hepatic accumulation of gemcitabine after multiple oral and intravenous administration in mice.
by Veltkamp, Stephan A
116 Long-term platinum retention after treatment with cisplatin and oxaliplatin.
by Brouwers, Elke E M
117 Liquid chromatography-tandem mass spectrometric assay for the mutated BRAF inhibitor vemurafenib in human and mouse plasma.
by Sparidans, Rolf W
118 The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib.
by Oostendorp, Roos L
119 Liquid chromatography-tandem mass spectrometric assay for ponatinib and N-desmethyl ponatinib in mouse plasma.
by Sparidans, Rolf W
120 Quantitative bioanalytical assay for the tropomyosin receptor kinase inhibitor larotrectinib in mouse plasma and tissue homogenates using liquid chromatography-tandem mass spectrometry.
by Sparidans, Rolf W